Abstract
Motor abnormalities dominate the clinical picture of Parkinson’s disease. Bradykinesia, caused by severe damage to the ascending nigrostriatal dopaminergic projection, leads to a slight hesitancy in initiating voluntary acts, a difficulty in performing repetitive movements with a progressive reduction in their amplitude, a poorly defined fatigue and possibly an additional defect of motor intention. Many patients also have an inability to attend to two motor commands simultaneously, and more complex perceptual-motor abnormalities have also been detected. Muscle rigidity, a coarse resting tremor and postural instability compound the patient’s incapacities, all of which are exquisitely influenced by the emotions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J psychiatry 135: 216–223
Agid Y, Ruberg M, Dubois B, Javoy-Agid F (1984) Biochemical substrates of mental disturbances in Parkinson’s disease. In: Hassler RG, Christ JF (eds) Advances in neurology, vol 40. Raven, New York, pp 22–218
Albert ML (1978) Subcortical dementia. In: Katzman R, Terry RD, Rick KL (eds) Alzheimer’s disease. Senile dementia and related disorders. Raven, New York, pp 173–180
Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121–130
Alvord EC, Forno LS, Kusske JA, Kauffman RJ, Rhodes JS, Goetowsky CR (1974) The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brain-stem. In: McDowell FH, Barbeau A (eds) Advances in Neurology, vol 5. Raven, New York, pp 175–193
Ball B (1882) De l’insanité dans la paralysie agitante. Encephale 2: 22–32
Barbeau A (1973) Biology of the striatum. In: Gall GE (ed) Biology and brain dysfunction, vol 2. Plenum, New York, pp 333–350
Boller F, Mizutani J, Roessman U, Gambetti P (1980) Parkinson’s disease, dementia and Alzheimer’s disease: clilnico-pathological correlations. Ann Neurol 7: 329–335
Bowen FP (1976) Behavioural alterations in patients with basal ganglia lesions. In: Yahr MD (ed) The basal ganglia. Raven, New York, pp 169–180
Bowen FP, Kamienny RS, Burns MM, Yahr MD (1975) Parkinsonism: effects of levodopa on concept formation. Neurology 25: 701–704
Brown RG, Marsden CD, Quinn N, Wyke MA (1984) Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson’s disease. J Neurol Neurosurg Psychiatry 47: 454–465
Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1983) Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases. J Neurol Sci 54: 59, 277–289
Celesia GC, Wanamaker WM (1972) Psychiatric disturbances in Parkinson’s disease. Dis New Syst 33: 577–583
Cools AR, Van den Bercken JHL, Horstink MWI, Van Spaendonck KPM, Berger HJC (1984) Cognitive and motor shifting aptitude disorder in Parkinson’s disease. J Neurol Neurosurg Psychiatry 47: 443–453
De Ajuriaguerra J (1971) Etude psychopathologique des parkinsoniens. In: De Ajuriaguerra J, Gauthier R (eds) Monoamines, noyaux gris centraux et syndromes parkinsoniens. Masson, Paris, pp 327–351
Delis D, Direnfeld L, Alexander MP, Kaplan E (1982) Cognitive fluctuations associated with on-off phenomenon in Parkinson disease. Neurology 32: 1049–1052
Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y (1983) A subcortico-cortical cholinergic system is affected in Parkinson’s disease. Brain Res 288: 213–218
Epelbaum J, Ruberg M, Moyse E, Javoy-Agid F, Dubois B, Agid Y (1983) Somatostatin and dementia in Parkinson’s disease. Brain Res 278: 376–379
Evarts EV, Teravainen H, Calne DB (1981) Reaction time in Parkinson’s disease. Brain 104: 167–186
Folstein MF, McHugh PR (1978) Dementia syndrome of depression. In: Katzman R, Terry RD, Bick KL (eds) Alzheimer’s disease, senile dementia and related disorders. Ageing vol7. Raven, New York, pp 87–93
Forno LS, Barbour PJ, Norville RL (1978) Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 35: 818–822
Goodwin FK, Brodie HK, Murphy DL, Bunney WE (1970) Administration of a peripheral de-carboxylase inhibitor with L-dopa to depressed patients. Lancet 1: 908–911
Hakim AM, Mathieson G (1979) Dementia in Parkinson’s disease: a neuropathologie study. Neurology 29: 1209–1214
Hardie RJ, Lees AJ, Stern GM (1984) On-off fluctuations in Parkinson’s disease: a clinical and pharmacological study. Brain 107: 487–506
Hassler R (1965) Extrapyramidal control of the speed of behaviour and its change by primary age processes. In: Welford AT, Birrin JT (eds) Behaviour ageing and the nervous system. Thomas, Springfield, pp 284–306
Jellinger K, Grissold W (1982) Cerebral atrophy in Parkinson’s syndrome. Exp. Brain Res [Suppl] 5: 26–35
Jouvent R, Abensour P, Bonnet AM, Widlocher D, Agid Y, L’Hermitte F (1983) Antiparkinsonian and antidepressant effects of high doses of bromocriptine. J Affective Disord 5: 141–145
Kay DWK (1972) Epidemiological aspects of organic brain disease in the aged. In: Galtz CM (ed) Ageing and the brain. Plenum, New York, pp 15–27
Laplane D, Bavlac M, Widlocher D, Dubois B (1984) Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry 47: 377–385
Lebensohn ZM, Jenkins RB (1975) Improvement of Parkinsonism in depressed patients treated with ECT. Am J Psychiatry 132: 283–285
Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106: 257–270
Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, Goldstein M (1979) Dementia in Parkinson’s disease. Ann Neurol 6: 355–359
Loranger AW, Goodell H, McDowell FH, Lee JE, Sweet RD (1972) Intellectual impairment in Parkinson’s syndrome. Brain 95: 405–412
Marttilla RJ, Rinne UK (1976) Dementia in Parkinson’s disease. Acta Neurol Scand 54: 431–441
Matison R, Mayeux R, Rosen J, Fahn S (1982) “Tip of the tongue” phenomenon in Parkinson’s disease. Neurology 32:567–570
Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment and Parkinson’s disease. Neurology 31: 645–650
McHugh PR, Folstein MF (1975) Psychiatric syndromes of Huntington’s chorea. A clinical and phenomenologic study. In: Benson DF, Blumer D (eds) Psychiatric aspects of neurologic disease. Grune and Stratton, New York, pp 267–288
Mettler FA (1955) Perceptual capacity, functions of the corpus striatum and schizophrenia. Psychiatr Q 29: 89–111
Mjönes H (1949) Paralysis agitans, a clinical and genetic study. Acta Psychiatr Neurol Scand [Suppl] 54: 1–195
Mortimer JA, Pirozzolo FJ, Hansch EC, Webster DD (1982) Relationship of motor symptoms to intellectual deficits in Parkinson disease. Neurology 32: 133–137
Nakano I, Hirano A (1984) Parkinon’s disease: neuron loss in the nucleus basalis without concomitant Alzheimer’s disease. Ann Neurol 15: 415–418
Naville F (1922) Etude sur les complications et les séquelles mentales de l’encephalite épidémique. La bradyphrénie. Encephalé 17:369–375, 424–436
Pearce J (1974) The extrapyramidal disorder of Alzheimer’s disease. Eur Neurol 12: 94–103
Pearce JMS, Flowers K, Pearce I, Pratt AE (1981) Clinical, psychometric and CAT scan correlations in Parkinson’s disease. In: Rose FC, Capildeo R (eds) Research progress in Parkinson’s disease. Pitman Medical, London, pp 43–52
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459
Pollock M, Hornabrook RW (1966) The prevalence, natural history and dementia of Parkinson’s disease. Brain 89: 429–448
Rajput AH, Offord K, Beard CM, Kurland LT (1984) Epidemiological survey of dementia in parkinsonism and control population. In: Hassler RG, Christ JF (eds) Adv Neurol, vol 40. Raven, New York, pp 229–234
Robins AH (1976) Depression in patients with Parkinsonism. Br J Psychiatry 128: 141–145
Rossor MN (1981) Parkinson’s disease and Alzheimer’s disease as disorders of the isodentritic core. Br Med J 283: 1588–1590
Selby G (1968) Cerebral atrophy in parkinsonism. J Neurol Sci 6: 517–559
Sharpe MH, Cermak SA, Sax DS (1983) Motor planning in Parkinsonian patients. Neuropsychologia 21: 455–462
Shaw KM, Lees Ai, Stern GM (1980) The impact of treatment with levodopa on Parkinson’s disease. Q J Med 49: 283–293
Sroka H, Elizan TS, Yahr MD, Burger A, Mendoza MR (1981) Organic mental syndrome and confusional states in Parkinson’s disease. Arch Neurol 38: 339–342
Steck H (1931) Les syndromes mentaux postencéphalitiques. Schweiz Arch Neurol Psychiatry 27: 137–173
Sweet RD, McDowell FH, Feigenson HS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson’s disease during crhonig treatment with levodopa. Neurology 26: 305–310
Todes CJ, Lees AJ (1985) The pre-morbid personality of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry (J. Neurol. Neurosurg. Psychiat. )
Van Praag HMV, Korf J, Lakke JPWF, Schut T (1975) Dopamine metabolism in depressions, psychoses and Parkinson’s disease: the problem of the specificity of biological variables in behaviour disorders. Psychol Med 5: 138–146
Warburton JW (1967) Memory disturbance and the Parkinson syndrome. Br J Med Psychol 40: 169–171
Whitehouse PJ, Price DL, Clark AW, Coyle JT, De Long MR (1981) Alzheimer’s disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10: 122–126
Whitehouse PJ, Hedreen JC, White CL, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 13: 243–248
Wilson RS, Kaszniak AW, Klawans HL, Garron DC (1980) High speed memory scanning in Parkinsonism. Cortex 16: 67–72
Wilson SAK (1940) In: Bruce AN (ed) Neurology. Chapter VIII, epidemic encephalitis. Arnold, London, pp 120, 132
Worster-Drought C, Hardcastle DN (1924) A contribution to the psychopathology of residual encephalitis lethargica. J Neurol Psychopathol 5: 146–150
Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of diffuse Lewy body disease. J Neurol 229: 17–32
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lees, A.J. (1985). Cognitive Deficits in Parkinson’s Disease. In: Traber, J., Gispen, W.H. (eds) Senile Dementia of the Alzheimer Type. Advances in Applied Neurological Sciences, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70644-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-70644-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70646-2
Online ISBN: 978-3-642-70644-8
eBook Packages: Springer Book Archive